Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00739518 · ClinicalTrials.gov registry record · NA
Refinement and Assessment of New Magnetic Resonance Imaging Technologies for Neurological Exams
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 500
- Enrollment target
NCT00739518: Completed NA study, sponsored by University of Michigan.
NCT00739518 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 500 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00739518, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
Study Summary
This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the brain, spine head and neck regions.
Primary Outcome
Specific Measurement Are: 1. Scan speed - is the new method as fast or faster than regular method(s) 2. Signal to noise - Subjectively, or quantitatively do we get the same, better, or new contrast compared to the regular methods(s). 3. Image contrast - Subjectively, or quantitatively do we get the same or better resolution compared to the regular method(s). 4. Spatial resolution - Subjectively, or quantitatively do we get the same or better resolution compared to the regular method(s). 5. Arti
Interventions
- PROCEDURE MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2004-10 |
| Est. Completion | 2020-01-14 |
| Phase | NA |
What the finished NCT00739518 record still lists
NCT00739518 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT00739518 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00739518 about?
NCT00739518 is a clinical study titled "Refinement and Assessment of New Magnetic Resonance Imaging Technologies for Neurological Exams". This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the brain, spine head and neck regions.
What is the current status of trial NCT00739518?
This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2004-10. Estimated completion is 2020-01-14.
What interventions are being tested in trial NCT00739518?
The interventions under investigation include: MRI (PROCEDURE).
Who is sponsoring clinical trial NCT00739518?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00739518's enrollment target sits among peer trials
500 193rd of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia